In-Hospital Bleeding in Elderly Patients With Acute Coronary Syndrome: Are Potent Antiplatelet Agents Safe?


KESKİN K., Sığırcı S., GÜRDAL A., Ser Ö. S., Kilci H., Sümerkan M. Ç., ...Daha Fazla

Angiology, cilt.73, sa.9, ss.827-834, 2022 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 73 Sayı: 9
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1177/00033197221075858
  • Dergi Adı: Angiology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Food Science & Technology Abstracts, MEDLINE
  • Sayfa Sayıları: ss.827-834
  • Anahtar Kelimeler: elderly, acute coronary syndrome, bleeding, ticagrelor, glycoprotein IIb, IIIa inhibitor
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Despite implementation of new interventional techniques and therapeutic advances, elderly patients with acute coronary syndrome (ACS) continue to be susceptible to in-hospital bleeding compared with younger ones. Thus, we investigated the incidence of in-hospital bleeding events and associated risk factors in elderly (≥ 75°years) ACS patients. We also wanted to define the bleeding sites, characteristics, and associated mortality. Bleeding Academic Research Consortium (BARC) classification type 2, 3, or 5 was used to define bleeding events. Overall, 539 patients were included in the study (mean age: 82.5 ± 4.8°years; 282 (52.3%) females). Of these patients, 69 (12.8%) developed in-hospital bleeding. Factors that were independently related with in-hospital bleeding were age (odds ratio (OR): 1.08; 95% confidence interval (CI): 1.011.14, P =.01), acute kidney injury (OR: 3.66; 95% CI: 2.016.69; P <.01), tirofiban (OR: 4.43; 95% CI: 1.7810.99; P <.01), and ticagrelor (OR: 1.93; 95% CI: 1.013.73; P =.04) administration. The urinary tract was the most frequent bleeding site, followed by femoral arteries. In conclusion, ticagrelor and tirofiban should be used with caution in elderly ACS patients.